Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38520925)

  • 1. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts.
    van Geffen EGM; Langhout JMA; Hazen SJA; Sluckin TC; van Dieren S; Beets GL; Beets-Tan RGH; Borstlap WAA; Burger JWA; Horsthuis K; Intven MPW; Aalbers AGJ; Havenga K; Marinelli AWKS; Melenhorst J; Nederend J; Peulen HMU; Rutten HJT; Schreurs WH; Tuynman JB; Verhoef C; de Wilt JHW; Marijnen CAM; Tanis PJ; Kusters M; On Behalf Of The Dutch Snapshot Research Group
    Eur J Cancer; 2024 May; 202():114021. PubMed ID: 38520925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study.
    Swartjes H; van Rees JM; van Erning FN; Verheij M; Verhoef C; de Wilt JHW; Vissers PAJ; Koëter T
    Ann Surg Oncol; 2023 Jul; 30(7):3915-3924. PubMed ID: 36790731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
    Br J Surg; 2017 Dec; 104(13):1866-1873. PubMed ID: 29023631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results.
    Sorrentino L; Belli F; Valvo F; Villa S; Guaglio M; Scaramuzza D; Gronchi A; Di Bartolomeo M; Cosimelli M
    Surg Oncol; 2020 Dec; 35():89-96. PubMed ID: 32858390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a history of metastases or synchronous metastases on survival in patients with locally recurrent rectal cancer.
    Voogt ELK; van Zoggel DMGI; Kusters M; Nieuwenhuijzen GAP; Cnossen JS; Creemers GJ; van Lijnschoten G; Nederend J; Roef MJ; Burger JWA; Rutten HJT
    Colorectal Dis; 2021 May; 23(5):1120-1131. PubMed ID: 33474793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?
    van Rees JM; Nordkamp S; Harmsen PW; Rutten H; Burger JWA; Verhoef C
    Eur J Surg Oncol; 2023 Sep; 49(9):106865. PubMed ID: 37002176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of surgery for locally recurrent and second recurrent rectal cancer with metastatic disease.
    Tanaka A; Uehara K; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Surg Oncol; 2020 Dec; 35():328-335. PubMed ID: 32979698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.
    Dresen RC; Gosens MJ; Martijn H; Nieuwenhuijzen GA; Creemers GJ; Daniels-Gooszen AW; van den Brule AJ; van den Berg HA; Rutten HJ
    Ann Surg Oncol; 2008 Jul; 15(7):1937-47. PubMed ID: 18389321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review.
    Fadel MG; Ahmed M; Malietzis G; Pellino G; Rasheed S; Brown G; Tekkis P; Kontovounisios C
    Cancer Treat Rev; 2022 Sep; 109():102419. PubMed ID: 35714574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.
    Selvaggi F; Fucini C; Pellino G; Sciaudone G; Maretto I; Mondi I; Bartolini N; Caminati F; Pucciarelli S
    Tech Coloproctol; 2015 Mar; 19(3):135-44. PubMed ID: 25384359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 18. Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre.
    Hagemans JAW; van Rees JM; Alberda WJ; Rothbarth J; Nuyttens JJME; van Meerten E; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2020 Mar; 46(3):448-454. PubMed ID: 31761506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.
    Holman FA; Bosman SJ; Haddock MG; Gunderson LL; Kusters M; Nieuwenhuijzen GA; van den Berg H; Nelson H; Rutten HJ
    Eur J Surg Oncol; 2017 Jan; 43(1):107-117. PubMed ID: 27659000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and prognosis of locally recurrent rectal cancer - A national population-based study.
    Westberg K; Palmer G; Hjern F; Johansson H; Holm T; Martling A
    Eur J Surg Oncol; 2018 Jan; 44(1):100-107. PubMed ID: 29224985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.